Healthcare -
Biotechnology - NASDAQ - US
$ 6.29
-4.26 %
$ 312 M
Market Cap
-1.26
P/E
RGNX - RESEARCH & DEVELOPMENT
Research & Development RGNX - REGENXBIO Inc.
232 M
LAST VALUE
13.14%
2 YEAR CAGR
22.59%
5 YEAR CAGR
46.64%
10 YEAR CAGR